FDG PET/CT and diffusion-weighted imaging for breast cancer: Prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 11, 2010, Pages 2011-2020

  Nakajo, Masatoyo ^a,d   Kajiya, Yoriko ^a   Kaneko, Tomoyo ^b   Kaneko, Youichi ^b   Takasaki, Takashi ^c   Tani, Atsushi ^a   Ueno, Masako ^a   Koriyama, Chihaya ^d   Nakajo, Masayuki ^d  

^a Nanpuh Hospital   (Japan)

^b Kaneko Clinic   (Japan)

^c Department of Pathology   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ADC; Breast cancer; FDG; MRI; Prognosis; SUV

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE DUCTAL CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; TUMOR VOLUME;

ADULT; AGED; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; DIFFUSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958513219     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1529-7     Document Type: Article

References (40)

1. P Rigo P Paulus BJ Kaschten R Hustinx T Bury G Jerusalem, et al. 1996 Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose Eur J Nucl Med 23 1641 1674 1:STN:280:DyaK2s%2FotlKktA%3D%3D 10.1007/BF01249629 8929320
2. WB Eubank DA Mankoff 2005 Evolving role of positron emission tomography in breast cancer imaging Semin Nucl Med 35 84 99 10.1053/j.semnuclmed.2004.11. 001 15765372
3. B Boné P Aspelin L Bronge B Isberg L Perbeck B Veress 1996 Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts Acta Radiol 37 208 213 8600964
4. LD Buadu J Murakami S Murayama N Hashiguchi S Sakai K Masuda, et al. 1996 Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis Radiology 200 639 649 1:STN:280:DyaK28zkslyhuw%3D%3D 8756909
5. Y Tamaki S Akashi-Tanaka T Ishida T Uematsu M Kusama Y Sawai, et al. 2002 3D imaging of intraductal spread of breast cancer and its clinical application for navigation surgery Breast Cancer 9 289 295 10.1007/BF02967606 12459708
6. SG Orel MD Schnall VA LiVolsi RH Troupin 1994 Suspicious breast lesions: MR imaging with radiologic-pathologic correlation Radiology 190 485 493 1:STN:280:DyaK2c7ht1ahug%3D%3D 8284404
7. KC Siegmann M Müller-Schimpfle F Schick CT Remy N Fersis P Ruck, et al. 2002 MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data AJR Am J Roentgenol 178 1403 1409 12034606
8. DM Koh T Takahara Y Imai DJ Collins 2007 Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body Magn Reson Med Sci 6 211 24 10.2463/mrms.6.211 18239358
9. T Kinoshita N Yashiro N Ihara H Funatu E Fukuma M Narita 2002 Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma J Comput Assist Tomogr 26 1042 1046 10.1097/00004728-200211000-00033 12488758
10. Y Guo YQ Cai ZL Cai YG Gao NY An L Ma, et al. 2002 Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging J Magn Reson Imaging 16 172 178 10.1002/jmri.10140 12203765
11. S Sinha FA Lucas-Quesada U Sinha N DeBruhl LW Bassett 2002 In vivo diffusion-weighted MRI of the breast: potential for lesion characterization J Magn Reson Imaging 15 693 704 10.1002/jmri.10116 12112520
12. Y Kuroki K Nasu S Kuroki K Murakami T Hayashi R Sekiuchi, et al. 2004 Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value Magn Reson Med Sci 3 79 85 10.2463/mrms.3.79 16093623
13. M Hatakenaka H Soeda H Yabuuchi Y Matsuo T Kamitani Y Oda, et al. 2008 Apparent diffusion coefficients of breast tumors: clinical application Magn Reson Med Sci 7 23 29 10.2463/mrms.7.23 18460845
14. M Oshida K Uno M Suzuki T Nagashima H Hashimoto H Yagata, et al. 1998 Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-[18F]-d-glucose Cancer 82 2227 2234 1:STN:280:DyaK1c3nt1agtg%3D%3D 10.1002/(SICI)1097-0142(19980601)82:11<2227:: AID-CNCR18>3.0.CO;2-W 9610703
15. T Inoue K Yutani T Taguchi Y Tamaki E Shiba S Noguchi 2004 Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-deoxy-2-fluoro-D- glucose-positron emission tomography J Cancer Res Clin Oncol 130 273 278 10.1007/s00432-003-0536-5 14986112
16. S Ueda H Tsuda H Asakawa T Shigekawa K Fukatsu N Kondo, et al. 2008 Clinicopathological and prognostic relevance of uptake level using 18F-fluodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer Jpn J Clin Oncol 38 250 258 10.1093/jjco/hyn019 18407934
17. Tavassoli FA, Devilee P. World Health Organization classification of tumors. Pathology and genetic of tumors of the breast and female genital organs. Lyon: IARC Press; 2003. p. 9-112.
18. CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 1:STN:280: DyaK38%2FpvVSltw%3D%3D 10.1111/j.1365-2559.1991.tb00229.x 1757079
19. Y Umekita M Souda Y Ohi Y Rai Y Sagara Y Sagara, et al. 2007 Expression of estrogen receptor α and progesterone receptor in normal human breast epithelium In Vivo 21 535 539 1:CAS:528:DC%2BD2sXnsVSjt78%3D 17591366
20. Y Umekita M Souda Y Ohi Y Sagara Y Rai T Takahama, et al. 2006 Expression of wild-type estrogen receptor β protein in human breast cancer: specific correlation with HER2/neu overexpression Pathol Int 56 423 427 1:CAS:528:DC%2BD28Xpt1yhtLg%3D 10.1111/j.1440-1827.2006.01983.x 16872435
21. SE Pinder IO Ellis M Galea S O'Rouke RW Blamey CW Elston 1994 Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up Histopathology 24 41 47 1:STN:280:DyaK2c7ptlWmsw%3D%3D 10.1111/j.1365-2559.1994.tb01269.x 8144141
22. CW Elston IO Ellis SE Pinder 1999 Pathological prognostic factors in breast cancer Crit Rev Oncol Hematol 31 209 223 1:STN:280: DC%2BD3c%2FgtFajtw%3D%3D 10.1016/S1040-8428(99)00034-7 10532196
23. L Bergkvist J de Boniface PE Jönsson C Ingvar G Liljegren J Frisell 2008 Axillary recurrence rate after negative sentinel node biopsy in breast cancer. Three-year follow-up of the Swedish multicenter cohort study Ann Surg 247 150 156 10.1097/SLA.0b013e318153ff40 18156935
24. WJ Youden 1950 Index for rating diagnostic tests Cancer 3 32 35 1:STN:280:DyaG3c%2FhsFeisw%3D%3D 10.1002/1097-0142(1950)3:1<32::AID- CNCR2820030106>3.0.CO;2-3 15405679
25. JS Ross JA Fletcher 1998 The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Stem Cell 16 413 428 1:STN:280:DyaK1M%2FkvVOjtQ%3D%3D 10.1002/stem.160413
26. N Ikenaga N Otomo A Toyofuku Y Ueda K Toyoda T Hayashi, et al. 2007 Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors Am Surg 73 1151 1157 18092653
27. F Crippa E Seregni R Agresti C Chiesa C Pascali A Bogni, et al. 1998 Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation Eur J Nucl Med 25 1429 1434 1:CAS:528:DyaK1cXmtFegt7g%3D 10.1007/s002590050319 9818284
28. A Mavi M Urhan JQ Yu H Zhuang M Houseni TF Cermik, et al. 2006 Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes J Nucl Med 47 1440 1446 16954551
29. N Avril M Menzel J Dose M Schelling W Weber F Jänicke, et al. 2001 Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 9 16 1:CAS:528: DC%2BD3MXhtF2nsLc%3D 11197987
30. R Woodhams K Matsunaga K Iwabuchi S Kan H Hata M Kuranami, et al. 2005 Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension J Comput Assist Tomogr 29 644 649 10.1097/01.rct.0000171913.74086.1b 16163035
31. MJ Park ES Cha BJ Kang YK Ihn JH Baik 2007 The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors Korean J Radiol 8 390 396 10.3348/kjr.2007.8.5.390 17923781
32. SH Kim ES Cha HS Kim BJ Kang JJ Choi JH Jung, et al. 2009 Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors J Magn Reson Imaging 30 615 20 10.1002/jmri.21884 19711411
33. Razek AA, Gaballa G, Denewer A, Nada N. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. NMR Biomed 2010. doi: 10.1002/nbm.1503
34. R Black R Prescott K Bers A Hawkins H Stewart P Forrest 1983 Tumor cellularity, oestrogen receptors and prognosis in breast cancer Clin Oncol 9 311 318 1:STN:280:DyaL2c7gsleisg%3D%3D 6661854
35. K Tanaka D Yamamoto M Yamada H Okugawa 2004 Influence of cellularity in human breast carcinoma Breast 13 334 340 10.1016/j.breast.2004.02.002 15325670
36. P Kiruparan L Forrest 2007 Prediction in breast cancer of the extent of axillary node involvement from the size and lymphovascular invasion status of the primary tumor: medico-legal considerations Eur J Surg Oncol 33 435 437 1:STN:280:DC%2BD2s3jvVWqtg%3D%3D 10.1016/j.ejso.2006.10.031 17137746
37. YM El-Gohary G Metwally RS Saad MJ Robinson T Mesko RJ Poppiti 2008 Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas Am J Clin Pathol 129 578 586 10.1309/2HGNJ1GU57JMBJAQ 18343785
38. GH Sakorafas DR Farley 2003 Optimal management of ductal carcinoma in situ of the breast Surg Oncol 12 221 240 10.1016/S0960-7404(03)00031-8 14998563
39. N Biglia L Mariani L Sgro P Mininanni G Moggio P Sismondi 2007 Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment Endocr Relat Cancer 14 549 567 1:CAS:528:DC%2BD2sXhsVSisbfN 10.1677/ERC-06-0060 17914088
40. M Ueno T Kiba T Nishimura T Kitano K Yanagihara K Yoshikawa, et al. 2007 Changes in survival during the past two decades for breast cancer at the Kyoto University Hospital Eur J Surg Oncol 33 696 699 1:STN:280:DC%2BD2svgslGqtw%3D%3D 17376645